Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ·Healthcare·Biotechnology
$475.49
+1.03%
Mkt Cap $121.09B
Analyst Ratings
Buy
21
Hold
4
Sell
1
Price Target (93 analysts)
$553.93
Range $436.00 – $616.00
Implied Upside
+16.5%
Consensus $553.93 vs current $475.49